Search results
Author(s):
Eirik Ikdahl
,
Anne Kerola
,
Eli Sollerud
,
et al
Added:
1 year ago
Author(s):
Marianna Fontana
Added:
2 years ago
Prof Marianna Fontana (University College London, UK) joined us to discuss the discovery and impact of antibody-associated reversal of ATTR amyloidosis–related cardiomyopathy in three patients.
Prof Fontana and her team, in a correspondence published in The New England Journal of Medicine, revealed the identification of an antibody linked to the spontaneous reversal of cardiac transthyretin…
View more
Author(s):
Paul M Ridker
Added:
2 years ago
ACC.23/WCC - We are joined by Dr Paul Ridker (Brigham and Women’s Hospital, US) to discuss the findings from a collaborative analysis of 31,197 patients to assess inflammatory risk in statin-treated patients. The PROMINENT, REDUCE-IT and STRENGTH trials were each large contemporary trials which implemented guideline-directed medical therapy, the findings of which were pooled in this study. The…
View more
Erik Stroes
Research Area(s) / Expertise:
Job title: Chairman of the lipid clinic
Author
Cardiovascular Risk in NAFLD
Author(s):
Paula Luque-Linero
,
Jose M Guerra
Added:
1 year ago
Review Article
Immune Cell Traits and Heart Failure: A Mendelian Randomisation Study
Author(s):
Wei Gao
,
Hui Wang
,
Jian-long Wang
,
et al
Added:
4 months ago
Original Research
Author(s):
Tian-le Li
,
Mao-long Fu
,
Li-hong Wang
,
et al
Added:
11 months ago
Author(s):
Armin Arbab-Zadeh
,
Michelle Graham
,
Hector M Garcia-Garcia
,
et al
Added:
5 months ago
Factor XIa Inhibitors’ Future Position in AF
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
1 year ago
Expert Opinion